WELCOME CEREMONY: David Lewis, Jeanne Marrazzo, Mauro Romero L Passos
KEYNOTE LECTURE: HIV, STIs and evolution in global health. Kevin M. De Cock, US CDC, Kenya

STI & HIV Rio 2017 – SYMPOSIUM 1: New technologies for diagnosis, characteriza-tion and control of STIs/HIV. Chairs: Barbara Van Der Pol & Roberto Carvalho da Silva.

STI & HIV Rio 2017 – SYMPOSIUM 4: The digital age and sexual health: friend or foe?
Chairs: Sevgi Aral & Matthew Golden.
Integrating STI self-testing into an e Health prevention program for young MSM: The Keep It Up! 2.0 trial. Brian Mustanski, Northwestern University, USA.

STI & HIV Rio 2017 – PLENARY 4 & 5: Plenary 4: Refugees and HIV/STI trisk and responses. Paul Spiegel, Johns Hopkins Bloomberg School of Public Health, USA.
Plenary 5: Know your status: How we can harness the power of dating apps to educate and empower around HIV/STI prevention. Alex Garner, Hornet Gay Social Networking App, USA.

STI & HIV Rio 2017 – SYMPOSIUM 10: Tackling antimicrobial resistance in Neisseria gonorrhoeae: a need for a comprehensive and collaborative approach.
Chairs: Ranmini Kularathe & Edward Hook III
Linking control and ompact of AMR in N. gonorrhoeae to the global antimicrobial action plan. Pilar Ramon-Pardo, Pan American Health Organization.

STI & HIV Rio 2017 – PLENARY 9 & 10: Plenary 9: A new focus for social and behavioral research in the era of biomedical advances in STI and HIV treatment and prevention. Patricia Dittus, Centers for Disease Control and Prevention, USA.
Plenary 10: Lessons learned from the Zika epidemic: reproductive justice as a human right. Debora Diniz. University of Brasilia (Brazil) and Anis Institute of Bioethics.

STI & HIV Rio 2017 – DEBATE DAY 11: Evening plenary question period Chairs: Jeffrey Klausner & Valeria Saraceni
Debate: Global, national and local public health agencies should make PrEP available on-demand:
Matthew Golden, University of Washington, USA; Beatriz Grinsztejn, Oswaldo Cruz Foundation, Brazil.

STI & HIV Rio 2017 – DEBATE: Sexual education starting at age 4: Is it too early? Mark Schuster, Boston Children’s Hospital, USA. Dennis FOrtenberry. Indiana University, USA.

STI & HIV Rio 2017 – SYMPOSIUM 7: Noncondom-based interventions for STI control. Chairs: Christopher Fairley & Mariangela Freitas da Silveira.
Does doxycycline prophylaxis have a future? Jeffrey Klausner, University of California Los Angeles, USA. Vaccines for STI prevention in men who have sex eith men: immunisation thresholds, current status and future prospects. DAvid Regan, The University of New South Wales, Australia. Risk compensation in men who have sex with men in the era of biomedical (non-condom) interventions. Henry de Vries, University of Amsterdam, Netherlands.

STI & HIV Rio 2017 – PLENARY 11 & 12: PLENARY 11: TO BE OR NOT TO BE. Civil society and HIV: Why not the other STIs? Fabio Mesquita, World Health Organization.
PLENARY 12: The future of anal cancer prevention. Andrew Grulich. The University of New South Wales, Australia.

STI & HIV Rio 2017 – CLINICAL CASE SERIES: Chairs: Freddy Tinajeros & Mariangela Freitas da Silveira
Exotic Mycobacteria in a patient with HIV immunosuppression, Marcos Davi Gomes de Sousa
Penile verrucous squamous cell carcinoma in a patient with non-Hodgkin lymphoma, Natasha Tsekova Traykovich.

STI & HIV Rio 2017 – SATELLITE SYMPOSIA: ROCHE. Syphilis, Chamydia, Gonorrhoeae